FridayApr 30, 2021 12:10 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Offering Cost-Effective, Efficient BCI Solutions

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, has created two FDA-cleared products (the NeuroCap(TM) and NeuroEEG(TM)) that are nothing like other brain-computer interface (“BCI”) solutions in the market. It has been observed that “data collected from consumer-centric, low-cost BCIs are typically not as efficient or as pristine as that retrieved from research-grade conventional wired EEGs (electroencephalograms),” notes a recent article. “Many of the BCIs on the market are not gelled so that the consumer can easily fit the product themselves. They have far fewer electrodes and are designed for the ease of the…

Continue Reading

TuesdayApr 27, 2021 10:37 am

Brain Scientific Inc. (BRSF) Receives FDA Clearance for Next-Gen NeuroCap

BRSF announced it has FDA clearance for next-gen NeuroCap The newest version of the NeuroCap has added velcro strips, expanded size range to include pediatrics New device can stay on the patient’s head for up to four hours Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, announced it has received clearance from the FDA for its next-generation NeuroCap(TM) (https://ibn.fm/RYmMH). This device is an advanced electroencephalogram (“EEG”) electrode array used in routine clinical and research settings. Like the previous version, the newest version of the NeuroCap will help improve patient access to neurological care through its simplicity, cost efficiency and one-time…

Continue Reading

FridayApr 23, 2021 10:37 am

Brain Scientific Inc. (BRSF) Joins Forces with JelikaLite to Reduce Symptoms of Autism

BRSF and JelikaLite have joined forces in a clinical trial for reducing autism symptoms in children JelikaLite uses PRM therapy to reduce autism symptoms BRSF sees this as an important step forward in wider adoption of affordable, accessible EEG systems The neurology-focused medical device and software company Brain Scientific (OTCQB: BRSF) announced on March 16, 2021, it is collaborating with JelikaLite in a clinical trial. The clinical trial, which began in March 2021, is designed to potentially uncover new treatment options to reduce autism symptoms in children. The trial has 30 participants from two New York City locations. JelikaLite was…

Continue Reading

MondayApr 19, 2021 12:58 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Announces FY2020 Business, Financial Results

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has released its 2020 financial results and has filed its annual report for the fiscal year ended Dec. 31, 2020. Company highlights include bringing the production of NeuroCaps(TM) to the United States; launching the commercial roll-out of its NeuroEEG(TM) and NeuroCap(TM) on a limited basis in the United States market; establishing wholly owned subsidiaries in Russia and Poland; and a significant increase in research and development efforts. Furthermore, the company announced that it has filed a provisional patent application for a new long-term monitoring EEG cap; in addition, its proprietary NeuroCap is…

Continue Reading

ThursdayApr 15, 2021 11:22 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Delivering Readily-Available Solution Amid Growing Need

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, is fulfilling a growing need for improved neurological monitoring that is cost efficient, disposable and portable. When combating a highly contagious disease, disposable technology helps to ensure that the virus is not spread through equipment. Brain Scientific’s disposable EEG caps are designed for single use and also assist in shortening person-to-person contact due to ease of placement, decreasing transmission between staff and patient. “As health-care facilities and frontline workers move quickly to address COVID symptoms and provide effective treatment, disposable devices offer a solution to rapidly…

Continue Reading

MondayApr 12, 2021 12:36 pm

Brain Scientific Inc. (BRSF) Changing the Landscape by Tackling Neurology Deserts

Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology deserts Brain Scientific has developed tools that help providers in neurology deserts provide access to neurological care With explosion of telemedicine services and increased integration of advanced practice providers, neurologists' shortage may improve Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is directly tackling the shortage of neurologists in the United States with cutting-edge technologies. By creating cost-efficient, disposable and portable EEGs, BRSF makes neurology care more accessible without putting excess strain on the already overextended neurologist labor pool. Between 2001 and 2016, the American Academy of…

Continue Reading

ThursdayApr 08, 2021 1:14 pm

Brain Scientific Inc. (BRSF) Meeting the Needs of Neuro Research

BRSF is creating mobile, easy-to-use electroencephalogram (“EEG”) devices that enhance research integrity There is an increasing desire to understand the brain’s capabilities and harness them for healing Brain Scientific provides a cost-efficient, pre-gelled, disposable and wireless solution that provides the same signal quality as the traditional wired EEG A growing consumer market for brain-computer interface (“BCI”) technology has some researchers worried about the quality of the data being collected. Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has developed wireless, portable, easy-to-use electroencephalogram (“EEG”) devices that do not compromise research integrity. Data collected from consumer-centric, low-cost BCIs…

Continue Reading

MondayApr 05, 2021 3:09 pm

Brain Scientific Inc. (BRSF) Provides Affordable Solutions for COVID Studies

Researchers struggle to understand the immediate effects of COVID, with no clear census on the long-term neurological impact COVID-19 has shown itself to be unique in how it interacts with the brain Brain e-tattoos implanted in forehead will be next wave of innovation for neurology Brain Scientific (OTCQB: BRSF) is meeting the growing need for improved brain monitoring with cost-efficient, disposable, and portable cutting-edge technology. This last year has seen an increased demand for disposable neurological technology accessible to all, adaptable for widespread use, and that provides quick, reliable information on the patient’s condition. As the pandemic winds down, thanks…

Continue Reading

MondayMar 29, 2021 1:08 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Bringing Cost-Effective, Compact Solutions to Emergency Medicine

Brain Scientific (OTCQB: BRSF), with its low-cost, portable, wireless and easy-to-use electroencephalogram (“EEG”) devices, the NeuroCap(TM) and NeuroEEG(TM), has overcome the barriers preventing the use of EEGs in emergency settings. This means that patients and emergency departments can more readily realize numerous EEG benefits. An EEG can make the distinction between dementia and delirium, adequately determine the severity of a mild traumatic brain injury (“mTBI”), as well as identify nontraumatic causes of neurologic dysfunction such as syncope and vertigo. In contrast, head CTs or MRIs are not equipped to effectively perform any of these tasks, yet they are widely used.…

Continue Reading

WednesdayMar 17, 2021 9:33 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Collaboration with JelikaLite

Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, recently announced a collaboration with JelikaLite, a company developing Cognilum(TM), a non-invasive wearable photobiomodulation device that is being developed to increase the well-being of children living with autism, through a clinical trial. In the trial, “Transcranial Photobiomodulation for Reducing Autism Symptoms in Children,” brain treatments for children diagnosed with autism would be delivered through Cognilum, while Brain Scientific’s NeuroEEG, a wireless EEG device, will monitor brain activity. The trial is designed to provide researchers and clinicians an opportunity to potentially uncover new treatment options for reducing the symptoms…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered